Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 54% ± 26% | |
endothelial cell | 6 studies | 21% ± 4% | |
astrocyte | 6 studies | 36% ± 20% | |
oligodendrocyte precursor cell | 6 studies | 29% ± 8% | |
GABAergic neuron | 5 studies | 54% ± 21% | |
cardiac muscle cell | 4 studies | 23% ± 2% | |
oligodendrocyte | 4 studies | 29% ± 17% | |
fibroblast | 3 studies | 18% ± 1% | |
interneuron | 3 studies | 58% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 45% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 239.64 | 2638 / 2642 | 98% | 2.95 | 690 / 705 |
prostate | 100% | 119.75 | 244 / 245 | 91% | 2.03 | 458 / 502 |
kidney | 99% | 145.20 | 88 / 89 | 86% | 3.23 | 778 / 901 |
adrenal gland | 100% | 148.24 | 258 / 258 | 73% | 1.55 | 167 / 230 |
esophagus | 95% | 97.59 | 1376 / 1445 | 77% | 1.95 | 140 / 183 |
skin | 97% | 119.21 | 1762 / 1809 | 71% | 1.74 | 337 / 472 |
breast | 99% | 138.84 | 456 / 459 | 67% | 1.41 | 745 / 1118 |
pancreas | 99% | 96.26 | 324 / 328 | 67% | 1.15 | 119 / 178 |
lung | 97% | 107.60 | 562 / 578 | 60% | 1.31 | 698 / 1155 |
stomach | 100% | 159.05 | 358 / 359 | 51% | 0.94 | 146 / 286 |
ovary | 99% | 120.89 | 178 / 180 | 51% | 0.93 | 219 / 430 |
bladder | 100% | 149.29 | 21 / 21 | 47% | 0.92 | 239 / 504 |
thymus | 98% | 107.50 | 641 / 653 | 48% | 0.78 | 293 / 605 |
intestine | 99% | 117.22 | 952 / 966 | 46% | 0.77 | 245 / 527 |
liver | 98% | 110.60 | 221 / 226 | 46% | 0.85 | 185 / 406 |
uterus | 100% | 132.53 | 170 / 170 | 37% | 0.77 | 168 / 459 |
muscle | 99% | 123.74 | 798 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 116.55 | 1184 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 109.36 | 1309 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 226.21 | 840 / 861 | 0% | 0 | 0 / 0 |
spleen | 86% | 47.36 | 208 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 48% | 0.90 | 38 / 80 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.33 | 7 / 45 |
peripheral blood | 11% | 4.61 | 103 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.11 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008299 | Biological process | isoprenoid biosynthetic process |
GO_0007411 | Biological process | axon guidance |
GO_0035269 | Biological process | protein O-linked mannosylation |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070567 | Molecular function | cytidylyltransferase activity |
GO_0047349 | Molecular function | D-ribitol-5-phosphate cytidylyltransferase activity |
Gene name | CRPPA |
Protein name | D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein) (hISPD) D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein) |
Synonyms | ISPD |
Description | FUNCTION: Cytidylyltransferase required for protein O-linked mannosylation . Catalyzes the formation of CDP-ribitol nucleotide sugar from D-ribitol 5-phosphate . CDP-ribitol is a substrate of FKTN during the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity . Shows activity toward other pentose phosphate sugars and mediates formation of CDP-ribulose or CDP-ribose using CTP and ribulose-5-phosphate or ribose-5-phosphate, respectively . Not Involved in dolichol production . . |
Accessions | ENST00000676325.1 A4D126 A0A6Q8PG39 A0A6Q8PF75 ENST00000399310.3 [A4D126-2] A0A6Q8PHI3 ENST00000675257.1 ENST00000407010.7 [A4D126-1] ENST00000674759.1 |